133 related articles for article (PubMed ID: 23054816)
1. In silico study and validation of phosphotransacetylase (PTA) as a putative drug target for Staphylococcus aureus by homology-based modelling and virtual screening.
Morya VK; Dewaker V; Kim EK
Appl Biochem Biotechnol; 2012 Dec; 168(7):1792-805. PubMed ID: 23054816
[TBL] [Abstract][Full Text] [Related]
2. Designing of potential inhibitors against Staphylococcus aureus sortase A: Combined analogue and structure based approach with in vitro validation.
Raj KK; Ganesh Kumar V; Leela Madhuri C; Mathi P; Durga Lakshmi R; Ravi M; Sri Ramudu B; Venkata Rao SV; Ramachandran D
J Mol Graph Model; 2015 Jul; 60():89-97. PubMed ID: 26119984
[TBL] [Abstract][Full Text] [Related]
3. In silico modeling of the type 2 IDI enzymes of Bacillus licheniformis, Pseudomonas stutzeri, Streptococcus pyogenes, and Staphylococcus aureus for virtual screening of potential inhibitors of this therapeutic target.
Torktaz I; Shahbani Zahiri H; Akbari Noghabi K
J Mol Graph Model; 2013 Feb; 39():176-82. PubMed ID: 23280415
[TBL] [Abstract][Full Text] [Related]
4. Identification of Potential Inhibitors of MurD Enzyme of
Zheng X; Zheng T; Liao Y; Luo L
Molecules; 2021 Oct; 26(21):. PubMed ID: 34770835
[No Abstract] [Full Text] [Related]
5. Identification of a new class of FtsZ inhibitors by structure-based design and in vitro screening.
Chan FY; Sun N; Neves MA; Lam PC; Chung WH; Wong LK; Chow HY; Ma DL; Chan PH; Leung YC; Chan TH; Abagyan R; Wong KY
J Chem Inf Model; 2013 Aug; 53(8):2131-40. PubMed ID: 23848971
[TBL] [Abstract][Full Text] [Related]
6. Ligand-based pharmacophore modelling and screening of DNA minor groove binders targeting Staphylococcus aureus.
Vijayalakshmi P; Selvaraj C; Shafreen RM; Singh SK; Pandian SK; Daisy P
J Mol Recognit; 2014 Jul; 27(7):429-37. PubMed ID: 24895275
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel S-adenosyl-L-homocysteine hydrolase inhibitors through homology-model-based virtual screening, synthesis, and biological evaluation.
Khare P; Gupta AK; Gajula PK; Sunkari KY; Jaiswal AK; Das S; Bajpai P; Chakraborty TK; Dube A; Saxena AK
J Chem Inf Model; 2012 Mar; 52(3):777-91. PubMed ID: 22324915
[TBL] [Abstract][Full Text] [Related]
8. Virtual screening of potential inhibitor against FtsZ protein from Staphylococcus aureus.
Vijayalakshmi P; Nisha J; Rajalakshmi M
Interdiscip Sci; 2014 Dec; 6(4):331-9. PubMed ID: 25519150
[TBL] [Abstract][Full Text] [Related]
9. Effective interaction studies for inhibition of DNA ligase protein from Staphylococcus aureus.
Vijayalakshmi P; Daisy P
J Recept Signal Transduct Res; 2015 Feb; 35(1):15-25. PubMed ID: 25055026
[TBL] [Abstract][Full Text] [Related]
10. Crystal structures of a phosphotransacetylase from Bacillus subtilis and its complex with acetyl phosphate.
Xu QS; Jancarik J; Lou Y; Kuznetsova K; Yakunin AF; Yokota H; Adams P; Kim R; Kim SH
J Struct Funct Genomics; 2005 Dec; 6(4):269-79. PubMed ID: 16283428
[TBL] [Abstract][Full Text] [Related]
11. Subtractive genomics approach to identify putative drug targets and identification of drug-like molecules for beta subunit of DNA polymerase III in Streptococcus species.
Georrge JJ; Umrania VV
Appl Biochem Biotechnol; 2012 Jul; 167(5):1377-95. PubMed ID: 22415782
[TBL] [Abstract][Full Text] [Related]
12. Discovery of novel selective inhibitors of Staphylococcus aureus β-ketoacyl acyl carrier protein synthase III.
Lee JY; Jeong KW; Shin S; Lee JU; Kim Y
Eur J Med Chem; 2012 Jan; 47(1):261-9. PubMed ID: 22104972
[TBL] [Abstract][Full Text] [Related]
13. Binding mode analyses and pharmacophore model development for sulfonamide chalcone derivatives, a new class of alpha-glucosidase inhibitors.
Bharatham K; Bharatham N; Park KH; Lee KW
J Mol Graph Model; 2008 Jun; 26(8):1202-12. PubMed ID: 18096420
[TBL] [Abstract][Full Text] [Related]
14. First pharmacophore model of CCR3 receptor antagonists and its homology model-assisted, stepwise virtual screening.
Jain V; Saravanan P; Arvind A; Mohan CG
Chem Biol Drug Des; 2011 May; 77(5):373-87. PubMed ID: 21284830
[TBL] [Abstract][Full Text] [Related]
15. Structural analysis and molecular docking of potential ligands with chorismate synthase of Listeria monocytogenes: a novel antibacterial drug target.
Hossain MM; Roy PK; Mosnaz AT; Shakil SK; Hasan MM; Prodhan SH
Indian J Biochem Biophys; 2015 Feb; 52(1):45-59. PubMed ID: 26040111
[TBL] [Abstract][Full Text] [Related]
16. Pharmacophore identification and virtual screening for methionyl-tRNA synthetase inhibitors.
Bharatham N; Bharatham K; Lee KW
J Mol Graph Model; 2007 Mar; 25(6):813-23. PubMed ID: 16996282
[TBL] [Abstract][Full Text] [Related]
17. Exploring the structural features of Aspartate Trans Carbamoylase (TtATCase) from Thermus thermophilus HB8 through in silico approaches: a potential drug target for inborn error of pyrimidine metabolism.
Kanagarajan S; Mutharasappan N; Dhamodharan P; Jeyaraman M; Ramadas K; Jeyaraman J
J Biomol Struct Dyn; 2014 Apr; 32(4):591-601. PubMed ID: 23663010
[TBL] [Abstract][Full Text] [Related]
18. An in silico virtual screening study for the design of norovirus inhibitors: fragment-based molecular docking and binding free energy calculations.
Lundborg M; Ali E; Widmalm G
Carbohydr Res; 2013 Aug; 378():133-8. PubMed ID: 23582100
[TBL] [Abstract][Full Text] [Related]
19. Targeting essential cell wall lipase Rv3802c for potential therapeutics against tuberculosis.
Saravanan P; Avinash H; Dubey VK; Patra S
J Mol Graph Model; 2012 Sep; 38():235-42. PubMed ID: 23085165
[TBL] [Abstract][Full Text] [Related]
20. In silico approach towards identification of potential inhibitors of Helicobacter pylori DapE.
Mandal RS; Das S
J Biomol Struct Dyn; 2015; 33(7):1460-73. PubMed ID: 25204745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
